tiprankstipranks
Voyageur Pharmaceuticals (VYYRF)
OTHER OTC:VYYRF
US Market
VYYRF
Voyageur Pharmaceuticals
RESEARCH TOOLSreports

Voyageur Pharmaceuticals (VYYRF) Income Statement

2 Followers

Voyageur Pharmaceuticals Income Statement

Last quarter (Q4 2025), Voyageur Pharmaceuticals's total revenue was C$645.00, an increase of Infinity% from the same quarter last year. In Q4, Voyageur Pharmaceuticals's net income was C$-865.95K. See Voyageur Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 25Feb 25Feb 24Feb 23Feb 22
Total Revenue
C$ 11.69KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -1.22MC$ -1.57KC$ -2.19KC$ -2.91KC$ -2.25K
Operating Expenses
C$ 2.31MC$ 1.70MC$ 1.22MC$ 1.75MC$ 2.05M
Depreciation and Amortization
C$ 1.13KC$ 1.57KC$ 2.19KC$ 2.91KC$ 2.25K
EBITDA
C$ -3.53MC$ -1.71MC$ -1.22MC$ -1.75MC$ -2.05M
Operating Income
C$ -3.53MC$ -1.70MC$ -1.22MC$ -1.75MC$ -2.05M
Other Income/Expenses
C$ 0.00C$ -7.94KC$ -178.52KC$ -1.97KC$ -3.28K
Pretax Income
C$ -3.53MC$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05M
Net Income
C$ -3.53MC$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.01C$ -0.01C$ -0.02C$ -0.02
Diluted EPS
C$ -0.02C$ -0.01C$ -0.01C$ -0.02C$ -0.02
Weighted Average Shares Outstanding
 165.66M 137.63M 130.51M 107.83M 94.68M
Weighted Average Shares Outstanding (Diluted)
 165.66M 137.63M 130.50M 107.83M 94.68M
Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History